Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized heparin for prevention of ventilator-associated pneumonia
ACTRN12612000038897Phase 2Recruiting
- Sponsor
- A/Prof Robert Boots
- Start
- Feb 2011
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label trial of heparin in ventilator-associated pneumonia (VAP) (3 arms), sponsored by A/Prof Robert Boots. Primary endpoints: Incidence of ventilator-associated pneumonia, Time to ventilator-associated pneumonia and 1 more. Started Feb 2011; status: recruiting.
02
Drugs
heparin
03
Conditions
ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on ACTRN12612000038897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000038897.